决定异体 CAR T 细胞排斥与扩增的细胞和分子机制
Cellular and molecular mechanisms determining allogeneic CAR T cell rejection and expansion.
我们评估了11例接受单一批次cemacabtagene ansegedleucel(cema-cel)治疗的大B细胞淋巴瘤患者,cemacabtagene ansegedleucel是一种异体抗CD19 CAR T产品。
英文原题:A retrospective study on the clinicopathological and molecular features of 22 cases of natural killer/T-cell lymphoma in children and adolescents.
这些结果提示,儿童和青少年NKTCL的组织病理学和免疫组化特征与成人病例相似。
儿童和青少年自然杀伤/T细胞淋巴瘤(NKTCL)是一种罕见的T/NK细胞肿瘤。本研究旨在分析这种罕见淋巴瘤类型的临床病理学和遗传学特征。我们评估了22例年轻NKTCL患者的临床、组织病理学和分子特征,其中男性15例,女性7例,中位年龄为15岁。结果显示,鼻腔部位是最常受累的区域,而27.3%的病例中观察到非鼻腔部位。肿瘤细胞由小到大不等,19例(86.4%)表现出凝固性坏死。所有患者的肿瘤细胞CD3和细胞毒性标志物均为阳性。19例(86.4%)CD56阳性。在所有可用病例中均观察到CD5表达降低。CD30在15例(75.0%)中呈异质性表达。所有22例患者EBV均为阳性。在随访的19例患者中,7例(36.8%)死于该疾病,中位随访期为44个月。此外,接受放疗/化疗的患者与未治疗患者相比,OS显著更差。检测到高突变频率,包括KMT2C(5/5)、MST1(5/5)、HLA-A(3/5)和BCL11A(3/5),这些基因涉及修饰、肿瘤抑制和免疫监视。这些结果表明,儿童和青少年NKTCL的组织病理学和免疫组化特征与成人病例相似。确诊NKTCL后需要积极治疗。此外,遗传学分析可能有助于深入理解这种罕见疾病。
Natural killer/T-cell lymphoma (NKTCL) in children and adolescents is a rare type of T/NK cell neoplasms. The aim of the present study was to analyze the clinicopathological and genetic features of this rare entity of lymphoma. We evaluated the clinical, histopathological and molecular features of 22 young people with NKTCL, including 15 males and 7 females, with a median age of 15 years. The results revealed that the nasal site was the most involved region while non-nasal sites were observed in 27.3% out of all cases. The tumor cells were composed of small sized to large cells and 19 (86.4%) cases exhibited coagulative necrosis. The neoplastic cells in all patients were positive for CD3 and the cytotoxic markers. Nineteen (86.4%) cases were positive for CD56. Reduced expression of CD5 was observed in all available cases. CD30 was heterogeneously expressed in 15 (75.0%) cases. All 22 patients were EBV positive. Seven (36.8%) out of all the 19 patients during the follow-up died of the disease, and the median follow up period was 44 months. Moreover, patients treated with radiotherapy/chemotherapy showed significantly inferior OS compared with the untreated patients. High mutation frequencies were detected including KMT2C (5/5), MST1 (5/5), HLA-A (3/5) and BCL11A (3/5), which involved in modifications, tumor suppression and immune surveillance. These results suggest that NKTCL in children and adolescents exhibits histopathological and immunohistochemical features similar to the cases in adults. Active treatment is necessary after the diagnosis of NKTCL is confirmed. Furthermore, genetic analyse may provide a deep understanding of this rare disease.
MEMBER ACCOUNT
登录成功会直接打开下一页。